bpc 157 increases growth hormone BPC-157 Peptide Therapy Summary of adverse effects found

Diclofenac sodium extended-release tablets, like other NSAIDs, may cause serious CV side effects, such as MI or stroke, which may result in hospitalization and even death

Potential digestive complaints may include: Because BPC-157 originated from research involving gastric protective mechanisms, digestive effects remain an area of ongoing scientific interest

It contains BPC (Body Protection Compound) in the form of short-chain amino acids that promote soft tissue recovery, digestive balance, and neurological support

Prior to treatment, each client undergoes a thorough good faith exam before iv therapy is administered, including a review of past medical history and targeted screening questions (such as kidney or liver conditions that may affect the metabolism and clearance of IV vitamins)